| CD123-engager T cells as a novel immunotherapeutic for acute myeloid leukemia CL Bonifant, A Szoor, D Torres, N Joseph, MP Velasquez, K Iwahori, ... Molecular Therapy 24 (9), 1615-1626, 2016 | 89 | 2016 |
| Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies Á Szöőr, G Tóth, B Zsebik, V Szabó, Z Eshhar, H Abken, G Vereb Cancer letters 484, 1-8, 2020 | 88 | 2020 |
| The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell … G Tóth, Á Szöőr, L Simon, Y Yarden, J Szöllősi, G Vereb MAbs 8 (7), 1361-1370, 2016 | 88 | 2016 |
| T cells expressing CD19-specific engager molecules for the immunotherapy of CD19-positive malignancies MP Velasquez, D Torres, K Iwahori, S Kakarla, C Arber, T Rodriguez-Cruz, ... Scientific reports 6 (1), 27130, 2016 | 63 | 2016 |
| TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity C Govers, Z Sebestyén, J Roszik, M Van Brakel, C Berrevoets, Á Szöőr, ... The Journal of Immunology 193 (10), 5315-5326, 2014 | 59 | 2014 |
| Cisplatin and a potent platinum (IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic … O Vondálová Blanářová, I Jelínková, Á Szöőr, B Skender, K Souček, ... Carcinogenesis 32 (1), 42-51, 2011 | 49 | 2011 |
| Silencing the KCNK9 potassium channel (TASK-3) gene disturbs mitochondrial function, causes mitochondrial depolarization, and induces apoptosis of human melanoma cells D Nagy, M Gönczi, B Dienes, Á Szöőr, J Fodor, Z Nagy, A Tóth, T Fodor, ... Archives of dermatological research 306, 885-902, 2014 | 43 | 2014 |
| A small number of HER2 redirected CAR T cells significantly improves immune response of adoptively transferred mouse lymphocytes against human breast cancer xenografts G Tóth, J Szöllősi, H Abken, G Vereb, Á Szöőr International Journal of Molecular Sciences 21 (3), 1039, 2020 | 39 | 2020 |
| T cell-activating mesenchymal stem cells as a biotherapeutic for HCC A Szoor, A Vaidya, MP Velasquez, Z Mei, DL Galvan, D Torres, A Gee, ... Molecular Therapy-Oncolytics 6, 69-79, 2017 | 37 | 2017 |
| CD28 and 41BB costimulation enhances the effector function of CD19-specific engager T cells MP Velasquez, A Szoor, A Vaidya, A Thakkar, P Nguyen, MF Wu, H Liu, ... Cancer immunology research 5 (10), 860-870, 2017 | 36 | 2017 |
| Ragweed subpollen particles of respirable size activate human dendritic cells K Pazmandi, BV Kumar, K Szabo, I Boldogh, A Szoor, G Vereb, A Veres, ... PloS one 7 (12), e52085, 2012 | 30 | 2012 |
| CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti–PD-L1 Treatment V Volpin, T Michels, A Sorrentino, AN Menevse, G Knoll, M Ditz, ... Cancer Immunology Research 8 (9), 1163-1179, 2020 | 27 | 2020 |
| Rafts and the battleships of defense: The multifaceted microdomains for positive and negative signals in immune cells Á Szöor, J Szöllosi, G Vereb Immunology letters 130 (1-2), 2-12, 2010 | 27 | 2010 |
| T‐cell synapse formation depends on antigen recognition but not CD3 interaction: Studies with TCR: ζ, a candidate transgene for TCR gene therapy J Roszik, Z Sebestyén, C Govers, Y Guri, Á Szöőr, Z Pályi‐Krekk, G Vereb, ... European journal of immunology 41 (5), 1288-1297, 2011 | 25 | 2011 |
| Daprodustat accelerates high phosphate-induced calcification through the activation of HIF-1 signaling A Tóth, DM Csiki, B Nagy Jr, E Balogh, G Lente, H Ababneh, Á Szöőr, ... Frontiers in Pharmacology 13, 798053, 2022 | 24 | 2022 |
| Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms Á Szöőr, L Ujlaky-Nagy, G Tóth, J Szöllősi, G Vereb Cellular signalling 28 (2), 81-93, 2016 | 22 | 2016 |
| Cytolytic activity of CAR T cells and maintenance of their CD4+ Subset is critical for optimal antitumor activity in preclinical solid tumor models M Csaplár, J Szöllősi, S Gottschalk, G Vereb, Á Szöőr Cancers 13 (17), 4301, 2021 | 17 | 2021 |
| Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint R Bosire, P Nánási Jr, L Imre, B Dienes, Á Szöőr, A Mázló, A Kovács, ... PloS one 14 (11), e0224936, 2019 | 17 | 2019 |
| Hypoxia-inducible factor activation promotes osteogenic transition of valve interstitial cells and accelerates aortic valve calcification in a mice model of chronic kidney disease DM Csiki, H Ababneh, A Tóth, G Lente, Á Szöőr, A Tóth, C Fillér, T Juhász, ... Frontiers in Cardiovascular Medicine 10, 1168339, 2023 | 11 | 2023 |
| CD28 and 41BB costimulatory domains alone or in combination differentially influence cell surface dynamics and organization of chimeric antigen receptors and early activation … M Mezősi-Csaplár, Á Szöőr, G Vereb Cancers 15 (12), 3081, 2023 | 10 | 2023 |
Szöllősi JánosUniversity of DebrecenVerified email at med.unideb.hu
